Moreover, metformin treatment activates peroxisome proliferator–activated receptor γ coactivator 1-α (PGC-1α) in osteoblasts, promoting osteoblast survival and function in high-glucose condition and reversing osteopenia in diabetic mice [49]. The gene discussed is PPARGC1A; the disease is Osteopenia.